Search

Focus

Compare

Peers

EBR-B
PNW
CMS
CMS-PB
NMK-PC
LNT
MGEE

Market Movers

Gainers

DCRD +40.52%

Compare to NMK-PB vs. NMK-PB
CNXA +38.89%

Compare to NMK-PB vs. NMK-PB

Losers

PONO -29.84%

Compare to NMK-PB vs. NMK-PB
ITHX -27.59%

Compare to NMK-PB vs. NMK-PB

Most Active

GRA None%

Compare to NMK-PB vs. NMK-PB
XEC None%

Compare to NMK-PB vs. NMK-PB

v. 0.2.5

Palmy Investing

Anonymous

Lite Member
Home
Dashboards
Portfolios
Watchlists
Screeners
Stocks Lists/Ideas
Comparisons
Earnings
Dividends
M&A Tracker
Articles
More
Macro
Industries
Sectors
Controlling My Account
Log Out

Resources

Plans Disclaimer Contact TOS Imprint

Add NMK-PB to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Loading...

Profile

Company Name

Niagara Mohawk Power Corporation PFD 3.60%

Symbol

NMK-PB

Currency

USD

Exchange

New York Stock Exchange

Head Quarter

-, -

Sector

-

Industry

-

Website

ISIN

-

CIK

CUSIP

-

UEI

-

LEI

-

Business Description

-

Search

Focus

Compare

Peers

EBR-B
PNW
CMS
CMS-PB
NMK-PC
LNT
MGEE

Market Movers

Gainers

DCRD +40.52%

Compare to NMK-PB vs. NMK-PB
CNXA +38.89%

Compare to NMK-PB vs. NMK-PB

Losers

PONO -29.84%

Compare to NMK-PB vs. NMK-PB
ITHX -27.59%

Compare to NMK-PB vs. NMK-PB

Most Active

GRA None%

Compare to NMK-PB vs. NMK-PB
XEC None%

Compare to NMK-PB vs. NMK-PB

Analysing NMK-PB

Summary
Investor Relations

Financial Reporting

Income Statements
Cash Flow Statements
Balance Sheets
Resulting Ratios

Financials

Analysts
Dividend Payments
Government Awards
Insiders [Soon]
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Leadership & Strategy

Board & Officers
Business Intelligence
Employee Voice
ESG Scores [Soon]
Mergers and Acquisitions
Qualified Risks

Possible Catalysts

Clinical Trials [Soon]
H1B/PERM Strategy
Industry H&T [Soon]
Macro
News
Patents / Trademarks [Soon]
Peer Performance
Relevant Disputes [Soon]

Niagara Mohawk Power Corporation PFD 3.60%

None

None, None [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Clinical Trials [Soon]
H1B/PERM Strategy
Industry H&T [Soon]
Macro
News
Patents / Trademarks [Soon]
Peers Performance
Relevant Disputes [Soon]

News

Theses · Events · Sentiments

End of NMK-PB's Analysis

CIK: 1004315 CUSIP: - LEI: - UEI: -

Secondary Listings

NMK-PB has no secondary listings inside our databases.

Share Your Research

Share With The Community

Or Copy the Link